This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Nov;16(11):864-865.

doi: 10.1016/S1474-4422(17)30335-6. Epub 2017 Sep 29.

PML risk and natalizumab: the elephant in the room

Tobias Derfuss¹, Ludwig Kappos²

Affiliations

Affiliations

¹ Neurology Clinic and Policlinic, Departments of Medicine, Biomedicine, Clinical Research, and Biomedical Engineering, University Hospital Basel, University of Basel, Basel 4031, Switzerland.
² Neurology Clinic and Policlinic, Departments of Medicine, Biomedicine, Clinical Research, and Biomedical Engineering, University Hospital Basel, University of Basel, Basel 4031, Switzerland. Electronic address: ludwig.kappos@usb.ch.

PMID: 28969985
DOI: 10.1016/S1474-4422(17)30335-6

Comment

PML risk and natalizumab: the elephant in the room

Tobias Derfuss et al. Lancet Neurol. 2017 Nov.

. 2017 Nov;16(11):864-865.

doi: 10.1016/S1474-4422(17)30335-6. Epub 2017 Sep 29.

Authors

Tobias Derfuss¹, Ludwig Kappos²

Affiliations

¹ Neurology Clinic and Policlinic, Departments of Medicine, Biomedicine, Clinical Research, and Biomedical Engineering, University Hospital Basel, University of Basel, Basel 4031, Switzerland.
² Neurology Clinic and Policlinic, Departments of Medicine, Biomedicine, Clinical Research, and Biomedical Engineering, University Hospital Basel, University of Basel, Basel 4031, Switzerland. Electronic address: ludwig.kappos@usb.ch.

PMID: 28969985
DOI: 10.1016/S1474-4422(17)30335-6

No abstract available

PubMed Disclaimer

Comment on

Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies.
Ho PR, Koendgen H, Campbell N, Haddock B, Richman S, Chang I. Ho PR, et al. Lancet Neurol. 2017 Nov;16(11):925-933. doi: 10.1016/S1474-4422(17)30282-X. Epub 2017 Sep 29. Lancet Neurol. 2017. PMID: 28969984

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations